Generation of histocompatible tissues using nuclear transplantation

被引:223
作者
Lanza, RP
Chung, HY
Yoo, JJ
Wettstein, PJ
Blackwell, C
Borson, N
Hofmeister, E
Schuch, G
Soker, S
Moraes, CT
West, MD
Atala, A
机构
[1] Childrens Hosp, Lab Tissue Engn & Cellular Therapeut, Boston, MA 02115 USA
[2] Adv Cell Technol, Worcester, MA 01605 USA
[3] Harvard Univ, Sch Med, Boston, MA 02115 USA
[4] Mayo Clin & Mayo Fdn, Dept Surg, Rochester, MN 55905 USA
[5] Mayo Clin & Mayo Fdn, Dept Immunol, Rochester, MN 55905 USA
[6] Univ Miami, Sch Med, Dept Neurol, Miami, FL 33136 USA
关键词
D O I
10.1038/nbt703
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Nuclear transplantation (therapeutic cloning) could theoretically provide a limitless source of cells for regenerative therapy. Although the cloned cells would carry the nuclear genome of the patient, the presence of mitochondria inherited from the recipient oocyte raises questions about the histocompatibility of the resulting cells. In this study, we created bioengineered tissues from cardiac, skeletal muscle, and renal cells cloned from adult bovine fibroblasts. Long-term viability was demonstrated after transplantation of the grafts into the nuclear donor animals. Reverse transcription-PCR (RT-PCR) and western blot analysis confirmed that the cloned tissues expressed tissue-specific mRNA and proteins while expressing a different mitochondrial DNA (mtDNA) haplotype. In addition to creating skeletal muscle and cardiac "patches", nuclear transplantation was used to generate functioning renal units that produced urinelike fluid and demonstrated unidirectional secretion and concentration of urea nitrogen and creatinine. Examination of the explanted renal devices revealed formation of organized glomeruli- and tubule-like structures. Delayed-type hypersensitivity (DTH) testing in vivo and Elispot analysis in vitro suggested that there was no rejection response to the cloned renal cells. The ability to generate histocompatible cells using cloning techniques addresses one of the major challenges in transplantation medicine.
引用
收藏
页码:689 / 696
页数:8
相关论文
共 59 条
[1]  
AEBISCHER P, 1987, LIFE SUPPORT SYST, V5, P159
[2]   Renal therapy using tissue-engineered constructs and gene delivery [J].
Amiel, GE ;
Yoo, JJ ;
Atala, A .
WORLD JOURNAL OF UROLOGY, 2000, 18 (01) :71-79
[3]   Current and future modalities for functional renal replacement [J].
Amiel, GE ;
Atala, A .
UROLOGIC CLINICS OF NORTH AMERICA, 1999, 26 (01) :235-+
[5]  
Atala A., 1997, SYNTHETIC BIODEGRADA
[6]  
Atala A., 2001, Methods of tissue engineering, V1st
[7]   GENETICS OF HISTOCOMPATIBILITY IN MICE .1. NEW LOCI AND CONGENIC LINES [J].
BAILEY, DW .
IMMUNOGENETICS, 1975, 2 (03) :249-256
[8]  
Böstman OM, 2000, CLIN ORTHOP RELAT R, P216
[9]  
Cibelli J.B., 2001, J REGEN MED, V2, P25, DOI [10.1089/152489001753262168, DOI 10.1089/152489001753262168]
[10]   Parthenogenetic stem cells in nonhuman primates [J].
Cibelli, Jose B. ;
Grant, Kathleen A. ;
Chapman, Karen B. ;
Cunniff, Kerrianne ;
Worst, Travis ;
Green, Heather L. ;
Walker, Stephen J. ;
Gutin, Philip H. ;
Vilner, Lucy ;
Tabar, Viviane ;
Dominko, Tanja ;
Kane, Jeff ;
Wettstein, Peter J. ;
Lanza, Robert P. ;
Studer, Lorenz ;
Vrana, Kent E. ;
West, Michael D. .
Science, 2002, 295 (5556)